Motor Performance and Muscle Mass as a Function of Hormonal Responses to Exercise

  • Marco A. Minetto
  • Andrea Benso
  • Ezio Ghigo
  • Fabio Lanfranco
Part of the Endocrine Updates book series (ENDO, volume 29)


Hormones, motoneurons, and skeletal muscle fibers represent the main actors in regulating the motor performance during acute physical exercise. Moreover, muscle growth in response to exercise conditioning is related to direct actions of hormones and autocrine/paracrine factors on skeletal muscle fibers. The aim of this chapter is to illustrate the main interactions that take place between the neuro-endocrine and neuro-muscular systems in response to acute exercise and to review the main hormonal mechanisms that underlie the structural growth and remodeling of skeletal muscle fibers in response to chronic exercise training.


Satellite Cell Locus Coeruleus Muscle Growth Skeletal Muscle Fiber Spinal Motoneuron 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Duchateau J, Semmler JG, Enoka RM. Training adaptations in the behavior of human motor units. J Appl Physiol 2006;101:1766–1775.CrossRefPubMedGoogle Scholar
  2. 2.
    Heckman CJ, Lee RH, Bronstone RM. Hyperexcitable dendrites in motoneurons and their neuromodulatory control during motor behaviour. Trends Neurosci 2003;26:688–695.CrossRefPubMedGoogle Scholar
  3. 3.
    Brownstone RM. Beginning at the end: repetitive firing properties in the final common pathway. Prog Neurobiol 2006;78:156–172.CrossRefPubMedGoogle Scholar
  4. 4.
    Chrousos GP. The hypothalamic–pituitary–adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351–1362.CrossRefPubMedGoogle Scholar
  5. 5.
    Valentino RJ, Foote SL, Page ME. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann N Y Acad Sci 1993;697:173–188.CrossRefPubMedGoogle Scholar
  6. 6.
    Van Bockstaele EJ, Colago EEO, Valentino RJ. Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol 1996;364:523–534.CrossRefPubMedGoogle Scholar
  7. 7.
    Curtis AL, Florin-Lechner SM, Pavcovich LA, et al. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J Pharmacol Exp Ther 1997;281:163–172.PubMedGoogle Scholar
  8. 8.
    Sakanaka M, Shibasaki T, Lederis K. Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. J Comp Neurol 1987;260:256–298.CrossRefPubMedGoogle Scholar
  9. 9.
    Price ML, Curtis AL, Kirby LG, et al. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 1998;18:492–502.CrossRefPubMedGoogle Scholar
  10. 10.
    Waselus M, Valentino RJ, Van Bockstaele EJ. Ultrastructural evidence for a role of gamma-aminobutyric acid in mediating the effects of corticotropin-releasing factor on the rat dorsal raphe serotonin system. J Comp Neurol 2005;482:155–165.CrossRefPubMedGoogle Scholar
  11. 11.
    Owczarek J, Jasińska M, Orszulak-Michalak D. Drug-induced myopathies. An overview of the possible mechanisms. Pharmacol Rep 2005;57:23–34.PubMedGoogle Scholar
  12. 12.
    Wu FC. Endocrine aspects of anabolic steroids. Clin Chem 1997;43:1289–1292.Google Scholar
  13. 13.
    Goldspink G. Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload. J Anat 1999;194:323–334.CrossRefPubMedGoogle Scholar
  14. 14.
    Kaplan SA, Cohen P. The somatomedin hypothesis 2007: 50 years later. J Clin Endocrinol Metab 2007;92:4529–4535.CrossRefPubMedGoogle Scholar
  15. 15.
    Brink M, Price SR, Chrast J, et al. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 2001;142:1489–1496.CrossRefPubMedGoogle Scholar
  16. 16.
    O’Connor JC, McCusker RH, Strle K, et al. Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell Immunol 2008;252:91–110.CrossRefPubMedGoogle Scholar
  17. 17.
    Quinn LS, Haugk KL, Grabstein KH. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology 1995;136:3669–3672.CrossRefPubMedGoogle Scholar
  18. 18.
    Quinn LS, Haugk KL, Damon SE. Interleukin-15 stimulates C2 skeletal myoblast differentiation. Biochem Biophys Res Commun 1997;239:6–10.CrossRefPubMedGoogle Scholar
  19. 19.
    Navegantes LC, Migliorini RH, do Carmo Kettelhut I. Adrenergic control of protein metabolism in skeletal muscle. Curr Opin Clin Nutr Metab Care 2002;5:281–286.CrossRefPubMedGoogle Scholar
  20. 20.
    Simonides WS, van Hardeveld C. Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle. Thyroid 2008;18:205–216.CrossRefPubMedGoogle Scholar
  21. 21.
    Chargé SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004;84:209–238.CrossRefPubMedGoogle Scholar
  22. 22.
    Hill M, Goldspink G. Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J Physiol 2003;549:409–418.CrossRefPubMedGoogle Scholar
  23. 23.
    McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997;387:83–90.CrossRefPubMedGoogle Scholar
  24. 24.
    Schuelke M, Wagner KR, Stolz LE, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004;350:2682–2688.CrossRefPubMedGoogle Scholar
  25. 25.
    Filigheddu N, Gnocchi VF, Coscia M, et al. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell 2007;18:986–994.CrossRefPubMedGoogle Scholar
  26. 26.
    Lebrasseur NK, Coté GM, Miller TA, et al. Regulation of neuregulin/ErbB signaling by ­contractile activity in skeletal muscle. Am J Physiol Cell Physiol 2003;284:C1149–C1155.PubMedGoogle Scholar
  27. 27.
    van der Hoeven JH. Decline of muscle fiber conduction velocity during short-term high-dose methylprednisolone therapy. Muscle Nerve 1996;19:100–102.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Marco A. Minetto
    • 1
  • Andrea Benso
  • Ezio Ghigo
  • Fabio Lanfranco
  1. 1.Division of Endocrinology and Metabolism, Department of Internal MedicineUniversity of TurinTurinItaly

Personalised recommendations